Breaking News Instant updates and real-time market news.

WCG

WellCare

$117.63

1.25 (1.07%)

08:33
10/06/16
10/06
08:33
10/06/16
08:33

WellCare receives NCQA quality accreditation for Kentucky Medicaid health plan

WellCare announced that the National Committee for Quality Assurance has awarded an accreditation status of Commendable to its Medicaid health plan in Kentucky. WellCare also has an Accredited designation for its Medicare Advantage plan in the state.

  • 01

    Nov

WCG WellCare
$117.63

1.25 (1.07%)

05/13/16
RBCM
05/13/16
NO CHANGE
RBCM
Health insurance weakness on court decision overdone, says RBC Capital
RBC Capital believes that the weakness in health insurer stocks in response to a federal judge's decision in the House versus Burwell case is overdone. The firm predicts that the decision will be overturned on appeal. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
06/13/16
SUSQ
06/13/16
NO CHANGE
Target $136
SUSQ
Positive
WellCare price target raised to $136 from $107 at Susquehanna
Susquehanna raised its price target on WellCare to $136 from $107 based on the view that it remains the divestee of choice for the Aetna (AET) and Humana (HUM) transaction. Susquehanna reiterated its Positive rating on WellCare shares.
06/15/16
LEER
06/15/16
NO CHANGE
Target $155
LEER
Outperform
Cigna could pursue other options if Anthem deal breaks, says Leerink
Leerink analyst Ana Gupte sees an acquisition of WellCare (WCG) or Molina Healthcare (MOH) by Cigna (CI) as potentially likely if the Anthem (ANTM) deal breaks. A Cigna combination with WellCare or Molina can be "strategically attractive" given the entry for Cigna into Medicaid and particularly Dual Eligibles markets, the analyst tells investors in a research note. While Gupte does not expect either company to entertain a transaction in the near-term, she believes a deal could be possible at the right price. The analyst recently lowered her Anthem-Cigna deal probability from 70% to under 50% on antitrust challenges exacerbated by management conflicts. She has an Outperform rating and $155 price target on Cigna's shares.
07/11/16
LEER
07/11/16
NO CHANGE
LEER
Outperform
WellCare more likely to win bid for Aetna Medical Advantage assets, says Leerink
Leerink analyst Ana Gupte views the reports that WellCare (WCG) and Centene (CNC) have bid for the package of Medical Advantage assets that are being auctioned off by Aetna (AET) to help close its transaction with Humana (HUM) as credible. The analyst sees WellCare as more likely to win the assets in this auction given their existing Medical Advantage presence. Leerink has an Outperform rating on both WellCare and Centene shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.